Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC
· Real-Time Price · USD
12.93
0.27 (2.13%)
At close: Aug 15, 2025, 3:59 PM
11.05
-14.54%
After-hours: Aug 15, 2025, 07:55 PM EDT
Benitec Biopharma Balance Sheet Statement
Financials in USD. Fiscal
year is
July - June.
Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Cash & Equivalents | 103.58M | 78.28M | 67.84M | 50.87M | 14.16M | 20.37M | 25.86M | 2.48M | 6.55M | 10.54M | 16.53M | 4.06M | 8.63M | 12.33M | 15.73M | 19.77M | 11.99M | 14.01M | 7.45M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 90K | 67K | 81K | 87K | 94K | 76K | 110K | 122K | 130K | 141K | 144K | 160K | 181K | 186K | 194K | 194K | 206K | 219K | 9K |
Receivables | 3K | 2K | 4K | 229K | 53K | 53K | 53K | 55K | 56K | 68K | 3K | 3K | 5K | 5K | 3K | 25K | 10K | 21K | 18K |
Inventory | n/a | n/a | n/a | 63K | 1.20 | 14K | 13K | 13K | n/a | -0.2 | 0.50 | 1.80 | n/a | n/a | n/a | n/a | n/a | n/a | 587K |
Other Current Assets | 424K | 428K | 490K | 516K | 157K | 355K | 482K | 1.18M | 788K | 14K | 13K | 14K | n/a | n/a | n/a | 15K | 409K | 352K | 1K |
Total Current Assets | 104.01M | 78.71M | 68.33M | 51.67M | 14.37M | 20.8M | 26.41M | 3.73M | 7.39M | 10.97M | 17.08M | 4.82M | 8.84M | 12.67M | 16.37M | 20.61M | 12.41M | 14.38M | 8.06M |
Property-Plant & Equipment | 1.11M | 288K | 358K | 449K | 539K | 451K | 531K | 613K | 695K | 789K | 890K | 993K | 1.04M | 1.16M | 1.27M | 577K | 815K | 910K | 851K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.2M | 355K | 439K | 536K | 633K | 527K | 641K | 735K | 825K | 930K | 1.03M | 1.15M | 1.22M | 1.34M | 1.46M | 771K | 1.02M | 1.13M | 860K |
Total Assets | 105.21M | 79.07M | 68.77M | 52.21M | 15M | 21.35M | 27.05M | 4.46M | 8.22M | 11.9M | 18.11M | 5.97M | 10.06M | 14.01M | 17.84M | 21.38M | 13.43M | 15.51M | 8.92M |
Account Payables | 433K | 593K | 903K | 1.35M | 815K | 2.62M | 1.53M | 1.14M | 635K | 531K | 608K | 422K | 100K | 682K | 323K | 274K | 1.64M | 87K | 299K |
Deferred Revenue | n/a | n/a | n/a | n/a | -292K | -2.62M | -1.53M | n/a | n/a | n/a | n/a | -1.2M | n/a | -1.26M | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | 137K | n/a | 284K | 292K | 286K | 280K | 275K | n/a | 263K | 258K | 252K | 232K | 213K | 194K | 213K | 208K | 203K | 198K |
Other Current Liabilities | 426K | 1.82M | 2.94M | 2.81M | 1.44M | 1.96M | 1.95M | 1.75M | 429K | 995K | 1.37M | 1.14M | 932K | 939K | 477K | 393K | 204K | 18K | 127K |
Total Current Liabilities | 7.03M | 3.09M | 4.55M | 4.92M | 3.44M | 5.75M | 4.53M | 3.98M | 3.15M | 2.49M | 3.01M | 2.53M | 1.91M | 2.48M | 1.6M | 1.37M | 2.44M | 779K | 1.02M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 38K | 41K | 38K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 613K | 38K | 41K | 38K | 62K | 137K | 211K | 284K | 354K | 422K | 491K | 559K | 635K | 698K | 760K | n/a | 54K | 108K | 161K |
Total Liabilities | 7.64M | 3.13M | 4.59M | 4.96M | 3.5M | 5.88M | 4.75M | 4.26M | 3.51M | 2.91M | 3.5M | 3.09M | 2.54M | 3.18M | 2.36M | 1.37M | 2.5M | 887K | 1.18M |
Total Debt | 959K | 137K | 211K | 284K | 354K | 423K | 491K | 559K | 623K | 685K | 749K | 811K | 867K | 911K | 954K | 213K | 262K | 311K | 359K |
Common Stock | 2K | 2K | 1K | 1K | n/a | n/a | n/a | n/a | 3K | 3K | 3K | 1K | 1K | 1K | 1K | 1K | 5K | 4K | 1K |
Retained Earnings | -212.03M | -202.68M | -195.32M | -190.26M | -184.92M | -180.64M | -173.84M | -167.89M | -163.23M | -158.83M | -153.42M | -148.33M | -143.26M | -139.99M | -135.16M | -130.12M | -126.12M | -122.21M | -119.34M |
Comprehensive Income | -716K | -688K | -993K | -892K | -835K | -952K | -780K | -830K | -853K | -898K | -738K | -1.25M | -1.51M | -1.27M | -1.22M | -1.46M | -1.59M | -1.57M | -1.77M |
Shareholders Equity | 97.57M | 75.94M | 64.18M | 47.25M | 11.5M | 15.47M | 22.31M | 202K | 4.71M | 8.99M | 14.61M | 2.88M | 7.52M | 10.84M | 15.47M | 20.01M | 10.93M | 14.63M | 7.74M |
Total Investments | n/a | n/a | n/a | 63K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |